Clinical Evidence & Translational Insights for Medicinal Plants
Your botanical claims deserve stronger evidence.
Scientific evidence and claims-risk reviews for botanical food, wellness, and supplement brands. Understand what published research supports, identify potential claims concerns, and develop more defensible product messaging.
Human-led scientific review · Fixed fee $950 · 7-business-day delivery
A good botanical story is not the same as substantiated marketing.
Our review tests whether the claimed benefit fits the ingredient actually sold, how it is prepared, and the research behind it.
Ingredient identity
Species, plant part, preparation and dose
Research relevance
Human evidence, study context and limitations
Claim interpretation
Evidence gaps, risk flags and wording options
Doctoral researcher
Pharmaceutical Sciences PhD Candidate
Botanical research
Phytochemistry and pharmacology
Relevant training
NSF Dietary Supplement Labeling Compliance course
Flagship service
Claim-Risk Snapshot
$950 fixed feeA focused scientific review of your product's agreed public-facing claims, mapped against published evidence and delivered as a concise written report.
What is included
- One botanical product, up to 10 agreed claims
- Up to three agreed brand-controlled pages or marketing materials
- Source-linked evidence and important study limitations
- Prioritized preliminary risk flags and evidence gaps
- Evidence-aligned wording options for further regulatory review
- A written summary with practical next steps
We distinguish ingredient forms, doses, and types of studies. A claim with limited evidence is not automatically unlawful, and a source-linked finding is not a regulatory sign-off.
See what the review looks like
Illustrative Claim-Risk Snapshot excerpt
An example of the evidence-to-claim reasoning in a paid review, not an assessment of a real brand or a complete report.
Open the sample claim assessment
Hypothetical product and claim
Ginger sparkling beverage: “Clinically proven to eliminate morning sickness.”
Research relevance
A systematic review of 12 randomized trials (1,278 participants) found improvement in pregnancy-related nausea with orally administered ginger, but not a statistically significant reduction in vomiting. Study preparations and doses cannot automatically substantiate this fictional beverage or an “eliminate” claim.
Source: Viljoen et al., 2014 · DOI ↗Preliminary flag
High priority · Do not use as written
The claimed certainty and treatment implication exceed what this evidence establishes for an uncharacterized beverage. Product-specific formulation, dose, audience, and regulatory context require review.
Lower-risk wording direction
“Made with ginger root” — only if factually correct. This is an ingredient description, not a substitute therapeutic claim; all proposed copy still requires context-specific review.
Illustrative scientific and preliminary claims-risk reasoning only. Regulatory background: FTC substantiation guidance ↗ · FDA food and supplement claim distinctions ↗
Scientific evidence assessment and preliminary claims-risk identification only. Not legal advice, comprehensive food-label compliance, mandatory-label review, laboratory testing, or final regulatory sign-off. Third-party press coverage is not automatically a brand claim; its inclusion requires an agreed scope and consideration of the brand's use of that content.
Research sourcing · exploratory pilot
Research peptide sourcing feasibility
PhytoCliniq is exploring a Jordan–U.S. sourcing pathway for custom synthetic peptides used in nonclinical research. We welcome conversations with laboratories and biotechnology teams about their technical specifications and sourcing challenges while we assess potential third-party suppliers.
Define research requirements
Clarify sequence, quantity, purity, modifications, intended nonclinical use, and required analytical documentation.
Assess potential suppliers
Evaluate stated synthesis capabilities, sample HPLC/MS records, quality documents, and export readiness.
Compare sourcing feasibility
Review quotations, lead times, shipping considerations, and purchasing requirements once credible suppliers are identified.
Exploratory inquiries welcome
This is a feasibility and supplier-discovery initiative, not an active peptide catalog or ordering service. No manufacturing partner has yet been qualified, and no peptide availability, delivery, or analytical quality is guaranteed. Research use only; no human or clinical use.
Simple, defined-scope engagement
How it works
A clear process from first conversation to your written evidence review.
Book a discovery call
Use a complimentary 20-minute call to confirm whether a scientific review adds value.
Agree on scope
Confirm the product, up to 10 claims, selected materials, fee and exclusions.
Scientific review
The 7-business-day timeline begins after scope agreement and receipt of required materials.
Receive your report
Get source-linked evidence, prioritized flags, wording directions and written next steps.
PhytoCliniq · Research Insights
From Plant Protein to Bioactive Peptide
The scientific evidence pathway — and where translation becomes challenging.
- 01
Plant source
Confirm botanical identity, plant part, and starting material
- 02
Peptide generation
Extraction, enzymatic hydrolysis, fermentation or isolation
- 03
Characterization
Sequence identification, HPLC purity, mass spectrometry
- 04
Bioactivity screening
Mechanistic assays, enzyme inhibition, cellular responses
- 05
Preclinical evaluation
Reproducibility, exposure, stability, toxicity and model relevance
- 06
Clinical translation
Human outcomes, safety, dose, product relevance and evidence limitations
Educational research framework; stages are illustrative, not evidence that a particular peptide has reached clinical use.
Selected literature: Ying et al., 2021 · Nirmal et al., 2024 · Sun et al., 2024
The scientist behind the service
Mana Kashuk, MSc, MBA
Founder, PhytoCliniq
Pharmaceutical Sciences PhD Candidate | Phytochemistry & Pharmacology
Mana Kashuk is a pharmaceutical sciences doctoral researcher whose work spans phytochemistry, natural products, and pharmacology. Her doctoral research includes botanical extraction, fractionation, analytical characterization, and pharmacological evidence interpretation.
PhytoCliniq combines evidence organization with human-led scientific review. Computational tools can accelerate the workflow; they do not replace examination of the underlying studies.
Relevant training includes NSF's Dietary Supplement Labeling Compliance course; this is not a credential for comprehensive conventional-food label sign-off.
Behind the scientific review
Technology supports the work. Scientific judgment leads it.
PhytoCliniq uses structured research workflows to organize botanical evidence and is developing internal ingredient-intelligence tools. These tools do not replace scientific assessment or regulatory and legal review.
Frequently asked questions
Before we work together
What does the $950 Claim-Risk Snapshot include?
One botanical product, up to 10 agreed claims, and up to three agreed brand-controlled pages or marketing materials. You receive a source-linked scientific review, preliminary claims-risk flags, and evidence-aligned wording options.
Does this replace legal or label-compliance review?
No. The Snapshot is a scientific evidence and preliminary claims-risk review, not legal advice, comprehensive food or dietary supplement label compliance, or a final regulatory sign-off.
Can you assess statements made in an interview or article?
Third-party press coverage is not automatically a brand claim. We can discuss whether and how that content is used by your brand, then agree in advance if it belongs in the review scope.
How quickly will I receive the report?
The defined-scope written report is delivered within 7 business days after we agree on the scope and receive all required materials. The complimentary 20-minute discovery call helps determine fit before an engagement.
Start with a conversation
Find out what the evidence supports.
A complimentary 20-minute discovery call helps us determine what your existing regulatory reviewer covers and whether a scientific claims review could add value.